Profile of:

Victoria Navarro Compán


Degree in Medicine and Surgery from the University of Seville. Specialist in Rheumatology at the Virgen Macarena University Hospital. Doctor from the University of Leiden in the Netherlands. Master's degree in epidemiology from the University of Maastricht. Master's degree in spondyloarthritis at the European University of Madrid. She spent two periods in international centres of excellence: the first of four months in the Charité-Universitätsmedizin in Berlin and the second of two and a half years in the Leiden University Medical Center. Since 2015, she combines clinical practice and research at the Hospital Universitario La Paz and teaching at the Universidad Rey Juan Carlos in Madrid (Spain), all of which focus on spondyloarthritis. She is currently a member of the executive committee of ASAS (Assessment of SpondyloArthritis Society), also acting as executive secretary.

Full name: Victoria Navarro Compán

Current country: Spain

Membership level: Full

Type of membership: EC

Number of publications: 15

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576480/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34893536/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34534275/

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey (2021)
https://pubmed.ncbi.nlm.nih.gov/34334361/

Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34144387/

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/30193774/

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group (2019)
https://pubmed.ncbi.nlm.nih.gov/31422357/

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29858176/

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28087505/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages (2016)
https://pubmed.ncbi.nlm.nih.gov/27752358/

Preliminary definitions of ‘flare’ in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative (2016)
https://pubmed.ncbi.nlm.nih.gov/26847821/

How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review (2014)
https://pubmed.ncbi.nlm.nih.gov/24970597/